David Gillespie

Dr. David Gillespie

Facultad de Medicina, Universidad de la Laguna, San Cristobal de La Laguna, Spain

Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010
Verified
Book Chapter
Closed access
JSJoanne Smith
Joanne Smith
LTLye Mun Tho
Lye Mun Tho
Naihan XuNaihan Xu
Naihan Xu
DGDavid Gillespie
David Gillespie

1 December 2009 in Cell
Verified
Journal Article
Closed access
Patricia A. J. MullerPatricia A. J. Muller
Patricia A. J. Muller
PCPatrick T. Caswell
Patrick T. Caswell
BDBrendan Doyle
Brendan Doyle
MIMarcin P. Iwanicki
Marcin P. Iwanicki
ETEe H. Tan
Ee H. Tan
KVKaren H. Vousden
Karen H. Vousden

1 February 2007 in Molecular Cell
Verified
Journal Article
Closed access
KAKotb Abdelmohsen
Kotb Abdelmohsen
RPRudolf Pullmann
Rudolf Pullmann
ALAshish Lal
Ashish Lal
HKHyeon Ho Kim
Hyeon Ho Kim
SGStefanie Galban
Stefanie Galban
MGMyriam Gorospe
Myriam Gorospe

15 March 2012 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
Naihan XuNaihan Xu
Naihan Xu
YLYuan-zhi Lao
Yuan-zhi Lao
YZYaou Zhang
Yaou Zhang
DGDavid Gillespie
David Gillespie
The Akt family of serine/threonine protein kinases are key regulators of multiple aspects of cell behaviour, including proliferation, survival, metabolism, and tumorigenesis. Growth-factor-activated Akt signalling promotes progression through normal, unperturbed cell cycles by acting on diverse downstream factors involved in controlling the G1/S and G2/M transitions. Remarkably, several recent studies have also implicated Akt in modulating DNA damage responses and genome stability. High Akt activity can suppress ATR/Chk1 signalling and homologous recombination repair (HRR) via direct phosphorylation of Chk1 or TopBP1 or, indirectly, by inhibiting recruitment of double-strand break (DSB) resection factors, such as RPA, Brca1, and Rad51, to sites of damage. Loss of checkpoint and/or HRR proficiency is therefore a potential cause of genomic instability in tumor cells with high Akt. Conversely, Akt is activated by DNA double-strand breaks (DSBs) in a DNA-PK- or ATM/ATR-dependent manner and in some circumstances can contribute to radioresistance by stimulating DNA repair by nonhomologous end joining (NHEJ). Akt therefore modifies both the response to and repair of genotoxic damage in complex ways that are likely to have important consequences for the therapy of tumors with deregulation of the PI3K-Akt-PTEN pathway.

10 May 2007 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
AMApolinar Maya-mendoza
Apolinar Maya-mendoza
EPEva Petermann
Eva Petermann
DGDavid Gillespie
David Gillespie
KCKeith W Caldecott
Keith W Caldecott
DJDean A Jackson
Dean A Jackson
The checkpoint kinase 1 (Chk1) preserves genome integrity when replication is performed on damaged templates. Recently, Chk1 has also been implicated in regulating different aspects of unperturbed S phase. Using mammalian and avian cells with compromised Chk1 activity, we show that an increase in active replicons compensates for inefficient DNA polymerisation. In the absence of damage, loss of Chk1 activity correlates with the frequent stalling and, possibly, collapse of active forks and activation of adjacent, previously suppressed, origins. In human cells, super‐activation of replication origins is restricted to pre‐existing replication factories. In avian cells, in contrast, Chk1 deletion also correlates with the super‐activation of replication factories and loss of temporal continuity in the replication programme. The same phenotype is induced in wild‐type avian cells when Chk1 or ATM/ATR is inhibited. These observations show that Chk1 regulates replication origin activation and contributes to S‐phase progression in somatic vertebrate cells.

1 February 2007 in Developmental Cell
Verified
Journal Article
Closed access
GZGeorge Zachos
George Zachos
EBElizabeth J. Black
Elizabeth J. Black
MWMark Walker
Mark Walker
MSMary T. Scott
Mary T. Scott
PVPaola Vagnarelli
Paola Vagnarelli
DGDavid Gillespie
David Gillespie